DOCS vs INTC Stock Comparison
Compare DOCS and INTC across AIQ Score, fundamentals, valuation, momentum, risk, analyst expectations and current market evidence.
What is the main difference between DOCS and INTC?
DOCS leads the current stock comparison as Doximity, Inc., with the clearest separation coming from quality and the broader AIQ evidence mix.
AlgovestIQ AIQ Comparison
Doximity, Inc. vs Intel Corp.
DOCS leads
DOCS leads by 13 AIQ points, primarily on Quality and Risk Resilience, but the lead has narrowed from 23 points over 30 sessions.
Competitive: 5 of 6 evidence groups support DOCS, and its lead is narrowing.
Doximity, Inc.
Intel Corp.
The Algovestiq AIQ Score currently favors DOCS over INTC, 57 versus 44 as of Sep 11, 2026. DOCS's advantage is driven primarily by stronger quality and risk resilience, while INTC holds the stronger momentum profile. DOCS also shows the stronger technical structure relative to its 50-day moving average. 5 of 6 covered evidence groups favor DOCS today, and the comparison is rated Competitive on stability: the leader's advantage has been narrowing. DOCS lead: Weakening — the AIQ differential moved from 23 to 13 points over 30 sessions.
Compare Doximity, Inc. and Intel Corp. across the Algovestiq AIQ Score, valuation, quality, momentum, risk, technicals and analyst expectations.
Performance over time
Price-return comparison using available daily close history.
Total return comparison
Growth of $10,000
Based on available close-price history. Distribution reinvestment is not added unless already reflected in the source series.
Compare DOCS and INTC against another ticker
Open a multi-ticker workspace without changing this focused pair page.
AIQ Factor Divergence
Where the two separate, on the four dimensions behind the AIQ Score. Bars read outward from a shared zero: further from the centre is a wider gap.
- Quality77 vs 39DOCS +38
- Momentum47 vs 77INTC +30
- Risk Resilience56 vs 28DOCS +28
- Value46 vs 30DOCS +16
5 of 6 evidence groups favor DOCS. DOCS’s edge is concentrated in quality and risk resilience; INTC keeps a meaningful momentum edge.
What changed since the last close
Latest scored session 2026-09-10, compared against the prior scored session 2026-09-09.
Largest factor move: Momentum +2
No new signals fired.
Largest factor move: Momentum -8
New signals
- EMA Ribbon Expansion Bullish — bullish, trend, medium horizon
DOCS's lead widened by 2 AIQ points in the latest snapshot.
Deeper signal detail for each name lives on its own signals page — DOCS and INTC both carry a full feed there.
The central trade-off
DOCS (Doximity, Inc.): the stronger current systematic profile, led by quality and risk resilience.
INTC (Intel Corp.): the counter-case, on momentum, technicals.
Which one fits your objective
The same two names rank differently depending on what you are optimizing for. All six reads are shown at once — none of them is hidden behind a toggle.
Balanced
DOCSDOCS on the overall AIQ Score, which weights Quality and Value most heavily.
Growth
DOCSDOCS on combined revenue and EPS growth.
Value
DOCSDOCS on the peer-relative Value factor, by 16 points.
Momentum
INTCINTC on the Momentum factor, by 30 points.
Lower downside
DOCSDOCS on Risk Resilience, by 28 points.
Analyst upside
DOCSDOCS on implied upside to the consensus price target.
AIQ vs Wall Street
Where the systematic read and the analyst consensus line up — and where they do not.
| Measure | DOCS | INTC | Note |
|---|---|---|---|
| Implied upside to target | +6.3% | -0.1% | DOCS has more room |
| Target dispersion | +84.6% | +136.1% | Lower is tighter analyst agreement |
| Consensus | Buy | Hold | Context, not a primary driver |
| Analysts covering | 14 | 27 | Higher coverage generally improves confidence |
Analyst targets are expectations, not predictions. Dispersion matters as much as the midpoint.
AIQ Agreement Matrix
5 of 6 covered evidence groups favor DOCS. A wide gap backed by one group is a weaker case than a narrow gap backed by five.
| Evidence group | Favors | Reading |
|---|---|---|
| AIQ Score | DOCS | 57 vs 44 |
| Fundamentals | DOCSon balance | revenue growth 7.7% vs 18.8%; EPS growth 30% vs -195.9%; TTM ROE 17% vs -10.8%; gross margin 88.1% vs 38.9% — DOCS takes 3 of 4 decided legs, not all of them |
| Valuation | DOCS | Value 46 vs 30 |
| Technicals | INTC | Price vs 50-day 8.7% vs 4.2%; vs 200-day -13.4% vs 33.4% |
| Risk Resilience | DOCS | Risk Resilience 56 vs 28 |
| Analyst expectations | DOCS | Target upside 6.3% vs -0.1% |
✓ agrees with the overall verdict · ✕ points the other way. Groups marked “not covered” lack data on one or both of DOCS and INTC and are excluded from the count.
AIQ Decision Stability
The two are close enough that your objective, not the score, should decide.
- The AIQ gap is wide at 13 points. (supports the conclusion holding)
- 5 of 6 covered evidence groups point the same way. (supports the conclusion holding)
- The leader's advantage has been narrowing. (argues the conclusion is provisional)
- Signal direction runs against the verdict: the leader is net-bearish while the laggard is net-bullish. (argues the conclusion is provisional)
- Analyst targets on the leader are widely dispersed. (argues the conclusion is provisional)
Stability combines the score gap, how broadly the evidence agrees, how steady the lead has been across daily snapshots, the current signal state on both names, and analyst dispersion on DOCS.
How the comparison changed
119 daily snapshots · May 4 – Sep 10DOCS lead: Weakening — the AIQ differential moved from 23 to 13 points over 30 sessions.
- Today
- DOCS +13
- 57 vs 44
- 7 sessions ago
- DOCS +27
- 62 vs 35
- 30 sessions ago
- DOCS +23
- 61 vs 38
- 90 sessions ago
- DOCS +30
- 63 vs 33
The lead has not changed hands in this window.
AIQ Signal Divergence
Only the signals that bear on the head-to-head. A conflicted name is carrying bullish and bearish rules at the same time — the technical evidence is not pointing one way.
0 bullish / 2 bearish / 2 neutral
- Death Cross Active — bearish, trend, long horizon (21.25%)
- Bollinger Band Squeeze — neutral, volatility, short horizon
- ATR Expansion - Breakout Mode — neutral, volatility, short horizon (5.35%)
4 bullish / 0 bearish / 1 neutral
- Golden Cross Active — bullish, trend, long horizon (31.44%)
- EMA Ribbon Expansion Bullish — bullish, trend, medium horizon
- Uptrend Structure Active — bullish, trend, long horizon
Price vs model alignment
Whether the latest session's price move confirms what the model did over the same session, or contradicts it.
Neither the price nor the AIQ Score moved enough in the latest session to confirm or contradict the other (price +3.52%, AIQ 0 points).
Price is up while the AIQ Score moved down 2 points over the same session — price and model disagree (price +2.61%, AIQ -2 points).
What would flip this result
A state, not a forecast. These are the specific, observable changes that would reverse the verdict — not a price prediction.
- 1INTC closes the Quality gap — currently 38 points behind, the largest single contributor to DOCS's edge.
- 2INTC's existing bullish trend signals translate into factor-score gains — the rules are already firing, but the scores have not yet followed.
- 3DOCS starts generating bearish momentum or trend signals.
- 4The narrowing continues — the lead has already given back 10 points over 30 sessions, and a further 13-point move would eliminate DOCS's advantage entirely.
The full evidence
Every number behind the verdict. The leader is called above each group so you are not left to solve it from the table.
Fundamentals
DOCS leads on balance| Metric | DOCS | INTC |
|---|---|---|
| Revenue growth (YoY) | 7.7% | 18.8% |
| EPS growth (YoY) | 30% | -195.9% |
| Gross margin | 88.1% | 38.9% |
| Operating margin | 29.6% | 0.1% |
| Return on equity (TTM) | 17% | -10.8% |
| Debt to equity | 0.01 | 0.58 |
Performance
INTC leads 5 of 6 windows| Metric | DOCS | INTC |
|---|---|---|
| 1 week (5 sessions) | -6.1% | 11.4% |
| 1 month (20 sessions) | -1.1% | -0.6% |
| 3 months (63 sessions) | 22.1% | -6.3% |
| 6 months (126 sessions) | 0.3% | 109.1% |
| Year to date | -44.2% | 171.9% |
| 1 year (252 sessions) | -64.5% | 309.8% |
Technicals
INTC has the stronger structure| Metric | DOCS | INTC |
|---|---|---|
| RSI (14) | 42.1 | 61.3 |
| ADX (14) | 35.7 | 15.5 |
| Price vs 50-day | 8.7% | 4.2% |
| Price vs 200-day | -13.4% | 33.4% |
| Volatility (1M, annualized) | 54.2% | 58.9% |
Risk
DOCS is the more resilient| Metric | DOCS | INTC |
|---|---|---|
| Beta | 0.63 | 2.89 |
| Sharpe ratio | -1.38 | 2.12 |
| Sortino ratio | -1.76 | 3.98 |
| Max drawdown | -76% | -41.9% |
| Current drawdown | -67.1% | -28.8% |
| Annualized volatility | 63.6% | 79.9% |
| Value at risk (95%) | -5.6% | -6.2% |
Straight answers
Each answer is regenerated from the current snapshot, not written once and left to age.
Which is better, DOCS or INTC?
On the Algovestiq AIQ Score, DOCS is the stronger of the two as of Sep 11, 2026, scoring 57 against INTC's 44. The edge comes from quality and risk resilience. INTC is not without a case — it holds the better momentum profile, which matters more if that is the objective you are optimizing for. This is a systematic score, not a recommendation: it ranks the two on the same evidence, it does not know your holding period or tax position.
Is DOCS or INTC the better buy right now?
DOCS carries the stronger systematic profile as of Sep 11, 2026, and the comparison is rated Competitive — 5 of 6 covered evidence groups agree. A Competitive rating means the two are close enough that your objective, not the score, should decide.
Why does the AIQ Score favor DOCS over INTC?
The composite weights Quality, Value, Momentum and Risk Resilience. DOCS leads Quality by 38 points; INTC leads Momentum by 30 points; DOCS leads Risk Resilience by 28 points. Where the two split, the factor with the larger weight carries the result.
Which has more analyst upside, DOCS or INTC?
Analyst price targets imply +6.3% upside for DOCS and -0.1% for INTC, so the Street currently favors DOCS. The model and the Street agree here, which is a broader base of evidence than either alone. Analyst targets are expectations, not predictions, and dispersion matters as much as the midpoint.
Which is better value, DOCS or INTC?
DOCS is the better-valued of the two on the peer-relative Value factor. DOCS on the peer-relative Value factor, by 16 points. The Value factor reads valuation relative to sector peers and to the company's own fundamental quality, so it is not the same as simply having the lower multiple.
Which has stronger growth, DOCS or INTC?
DOCS on combined revenue and EPS growth. Growth here is measured on reported revenue and earnings, not on forward estimates — it describes what the businesses have delivered, not what the Street expects next.
Which has stronger momentum, DOCS or INTC?
INTC on the Momentum factor, by 30 points. Momentum is one of the four weighted factors in the AIQ composite. It has documented persistence over three- to twelve-month horizons, which makes it a timing input rather than a reason to hold something indefinitely.
Which is riskier, DOCS or INTC?
DOCS is the more resilient of the two, so the other name carries the higher downside risk. DOCS on Risk Resilience, by 28 points. Risk Resilience is a weighted factor in the composite; position sizing usually responds to it more usefully than the buy/avoid decision does.
Is DOCS more profitable than INTC?
DOCS leads on the comparable margin measures — gross margin 88.1% vs 38.9%; operating margin 29.6% vs 0.1%; ttm roe 17% vs -10.8%.
Is DOCS's lead over INTC getting stronger or weaker?
DOCS lead: Weakening — the AIQ differential moved from 23 to 13 points over 30 sessions. This is measured from 119 daily comparison snapshots between 2026-05-04 and 2026-09-10. The lead has not changed hands in that window.
What would change the DOCS vs INTC verdict?
The result is a state, not a forecast, so it changes when the underlying evidence changes. Concretely: INTC closes the Quality gap — currently 38 points behind, the largest single contributor to DOCS's edge; INTC's existing bullish trend signals translate into factor-score gains — the rules are already firing, but the scores have not yet followed; DOCS starts generating bearish momentum or trend signals; the narrowing continues — the lead has already given back 10 points over 30 sessions, and a further 13-point move would eliminate DOCS's advantage entirely.
What do the current signals say about DOCS and INTC?
DOCS: 0 bullish / 2 bearish / 2 neutral. INTC: 4 bullish / 0 bearish / 1 neutral. The most decision-relevant rule on DOCS is Death Cross Active (bearish, long horizon). On INTC it is Golden Cross Active (bullish, long horizon).
Compare DOCS and INTC with others
Continue your research
This page answers which of the two. These answer the questions on either side of it.
How this comparison is scored
The Algovestiq AIQ Score composites four factors — Quality, Value, Momentum and Risk, each carrying a fixed weight. Sentiment is reported separately as SentimentPulse and is not folded into the composite. Scores refresh every trading day, and this page regenerates from the latest snapshot rather than being written once.
The verdict names a leader, states how broadly six independent evidence groups agree, and rates how durable that conclusion is given the score gap, its recent trajectory and the current signal state on both names.
How to use side-by-side comparison →This comparison is informational and educational, not investment advice. AIQ scores update daily; re-check after earnings, guidance or macro data that materially changes either name’s factor profile.